BSEInsider Trading / SAST26 Sept 2026 · 26 Sept 2026, 03:07 pm
Trading window shall remain closed from 01-10-2026 till 48 hours after declaration of UFR for the quarter ended September 30, 2026.
Samrat Pharmachem Ltd-$ · 530125
✦ AI Summary
Samrat Pharmachem Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its un-audited financial results for the quarter ended September 30, 2026, in compliance with SEBI regulations.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Samrat Pharmachem Ltd-$ - 530125 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
8d221969-8783-4486-9b8e-adbf77689474.pdf
View document text
September 26, 2026
Department of Corporate Services,
BSE Limited
P J Towers,
Dalal Street,
Mumbai - 400 001.
Ref: Scrip Code: 530125
Dear Sir/Madam,
Sub: Intimation of Closure of Trading Window for the quarter ended September 30, 2026
This is to inform you that in compliance with the requirements of SEBI (Prohibition of Insider Trading)
Regulations, 2015 and as per the terms of “Code of Conduct for Prevention of Insider Trading” of the
Company, the Trading Window of the Company shall remain closed (from Thursday, October 1, 2026
till 48 hours after the declaration of the Un-Audited Financial Results of the Company for the quarter
ended September 30, 2026) for all Designated Persons including their immediate relatives.
All the Designated Persons and their immediate relatives are prohibited to enter / deal in any transaction
involving sale or purchase or pledge of shares of the Company during the period of closure of Trading
Window.
No employee or insider shall deal in the shares of the Company while in possession of Unpublished
Price Sensitive Information.
This is for your information and record.
Thanking you,
Yours faithfully,
For Samrat Pharmachem Limited
Nishant Kankaria
Company Secretary and Compliance Officer